Literature DB >> 10535473

Duplex Doppler sonography in patients with Budd-Chiari syndrome.

Y Chawla1, S Kumar, R K Dhiman, S Suri, J B Dilawari.   

Abstract

BACKGROUND: Angiography has been the mainstay for diagnosis of Budd-Chiari syndrome even though other modalities are increasingly being used. We have evaluated our findings of duplex Doppler sonography (DDS) in patients with Budd-Chiari syndrome.
METHODS: Duplex Doppler sonography was performed in 37 consecutive angiographically proven patients with Budd-Chiari syndrome.
RESULTS: Real time ultrasonography showed abnormalities of right, middle and left hepatic veins (HV) in 21, 15 and 18 patients, respectively. Duplex Doppler sonography showed abnormal flow patterns in 37, 22 and 31 patients in the right, middle and left HV, respectively, thereby increasing the diagnostic yield by 40%. An abnormal waveform in one or more HV was present in all 37 patients. Uniphasic flow was the commonest abnormality and was seen in 22, nine and 14 patients, respectively, in the right, middle and left HV, while there was no flow in five, four and seven patients in the right, middle and left HV, respectively. Intrahepatic collaterals were seen in 35 of 37 patients (94.6%). Hepatopetal flow was found in the portal vein of 21 of 23 patients (91.3%), while flow was hepatofugal in one and portal vein thrombosis was found in another.
CONCLUSION: Duplex Doppler sonography is a useful procedure which helps in the diagnosis of patients with Budd-Chiari syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10535473     DOI: 10.1046/j.1440-1746.1999.01969.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Answers to multiple choice questions.

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-12

2.  Budd-Chiari syndrome: outcomes of endovascular intervention-A single-center experience.

Authors:  Nitin Jagtap; Mithun Sharma; Jagdeesh Singh; Manu Tandan; P N Rao; Rajesh Gupta; Sundeep Lakhtakia; Mohan Ramchandani; Harshal Shah; T Mahesh Kumar; Santosh Darishetty; G V Rao; D N Reddy
Journal:  Indian J Gastroenterol       Date:  2017-06-20

3.  MDCT venography in the evaluation of inferior vena cava in Budd-Chiari syndrome: a road less travelled.

Authors:  Hemant Deshmukh; Krantikumar Rathod
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb

4.  Hepatic vein waveforms in liver cirrhosis re-evaluated.

Authors:  Sudhamshu K C; Dilip Sharma; Saroj Prasad Chataut
Journal:  Hepatol Int       Date:  2010-12-17       Impact factor: 6.047

5.  Clinical and prothrombotic profile of hepatic vein outflow tract obstruction.

Authors:  Seema Alam; Rajeev Khanna; Amar Mukund
Journal:  Indian J Pediatr       Date:  2013-07-25       Impact factor: 1.967

6.  Nuclear medicine dynamic investigations in the diagnosis of Budd-Chiari syndrome.

Authors:  Mircea Dragoteanu; Ioan-Adrian Balea; Cecilia-Diana Piglesan
Journal:  World J Hepatol       Date:  2014-04-27

7.  Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: A meta-analysis.

Authors:  Peng Xu; Lulu Lyu; Muhammad Umair Sami; Xin Lu; Haitao Ge; Yutao Rong; Chunfeng Hu; Kai Xu
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

8.  Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment.

Authors:  Deepak N Amarapurkar; Sundeep J Punamiya; Nikhil D Patel
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 9.  Imaging of Budd-Chiari syndrome.

Authors:  O Buckley; J O' Brien; A Snow; H Stunell; I Lyburn; P L Munk; W C Torreggiani
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 7.034

10.  Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis.

Authors:  Pankaj Gupta; Varun Bansal; Praveen Kumar-M; Saroj K Sinha; Jayanta Samanta; Harshal Mandavdhare; Vishal Sharma; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2020-03-18       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.